QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Aptevo Therapeutics
(NASDAQ:APVO)
4.55
-0.28[-5.80%]
At close: May 20
4.22
-0.3300[-7.25%]
After Hours: 4:57PM EDT
Day High/Low4.33 - 4.88
52 Week High/Low3.45 - 31.76
Open / Close4.88 / 4.55
Float / Outstanding5M / 5M
Vol / Avg.23.8K / 202.4K
Mkt Cap22.8M
P/E-
50d Avg. Price4.93
Div / Yield-
Payout Ratio-
EPS-1.55
Total Float5M

Aptevo Therapeutics (NASDAQ:APVO), Quotes and News Summary

Aptevo Therapeutics (NASDAQ: APVO)

Day High/Low4.33 - 4.88
52 Week High/Low3.45 - 31.76
Open / Close4.88 / 4.55
Float / Outstanding5M / 5M
Vol / Avg.23.8K / 202.4K
Mkt Cap22.8M
P/E-
50d Avg. Price4.93
Div / Yield-
Payout Ratio-
EPS-1.55
Total Float5M
Benzinga - May 13, 2022, 6:38AM
Benzinga - May 12, 2022, 8:18AM
Benzinga - Apr 12, 2022, 8:11AM
Benzinga - Apr 7, 2022, 4:29PM
Benzinga - Mar 29, 2022, 8:06AM
Benzinga - Mar 24, 2022, 2:48PM
Benzinga - Mar 24, 2022, 10:57AM
Benzinga - Mar 24, 2022, 8:09AM
Benzinga - Feb 15, 2022, 11:41AM
Benzinga - Feb 9, 2022, 2:28PM
Benzinga - Feb 9, 2022, 10:54AM
Benzinga - Feb 9, 2022, 8:11AM
Benzinga - Jan 21, 2022, 8:24AM
Benzinga - Jan 21, 2022, 8:24AM
Benzinga - Dec 15, 2021, 8:08AM
Benzinga - Dec 14, 2021, 4:45PM
load more
Sector: Health Care.Industry: Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-1.150-1.550 -0.4000
REV3.750M3.114M-636.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Aptevo Therapeutics Questions & Answers

Q
How do I buy Aptevo Therapeutics (APVO) stock?
A

You can purchase shares of Aptevo Therapeutics (NASDAQ: APVO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Aptevo Therapeutics's (APVO) competitors?
Q
What is the target price for Aptevo Therapeutics (APVO) stock?
A

The latest price target for Aptevo Therapeutics (NASDAQ: APVO) was reported by Piper Sandler on Friday, May 13, 2022. The analyst firm set a price target for 20.00 expecting APVO to rise to within 12 months (a possible 339.56% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Aptevo Therapeutics (APVO)?
A

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $4.55 last updated May 20, 2022, 8:00 PM UTC.

Q
Does Aptevo Therapeutics (APVO) pay a dividend?
A

There are no upcoming dividends for Aptevo Therapeutics.

Q
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
A

Aptevo Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Aptevo Therapeutics (APVO) going to split?
A

There is no upcoming split for Aptevo Therapeutics.

Q
What sector and industry does Aptevo Therapeutics (APVO) operate in?
A

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.